Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer (Q81795330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

main subject

metastatic breast cancer

1 reference

Jin H Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Nilanjana Majumder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Honghui Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Janet Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Louis D Falo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Zhaoyang You

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

941-949

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

Cancer vaccines: between the idea and the reality

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Destination: tumor eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Strategies for designing and optimizing new generation vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

DNA vaccines: immunology, application, and optimization*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Exploiting dendritic cells to improve vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Dendritic cells as vectors for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Spinning molecular immunology into successful immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Dendritic cell immunotherapy: mapping the way.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Facets of heat shock protein 70 show immunotherapeutic potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

The makings of a tumor rejection antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Animal models of tumor immunity, immunotherapy and cancer vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

A novel orthotopic model of breast cancer metastasis to bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Cancer vaccines targeting the HER2/neu oncogenic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Metastasis to bone: causes, consequences and therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

CD40/CD154 interactions at the interface of tolerance and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Antigen bias in T cell cross-priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

CD8+ T cell cross-priming via transfer of proteasome substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Adoptive-cell-transfer therapy for the treatment of patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.003

10.1016/J.YMTHE.2005.01.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15922965%20AND%20SRC:MED&resulttype=core&format=json